Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) EPS (Weighted Average and Diluted): 2021-2024

Historic EPS (Weighted Average and Diluted) for Assembly Biosciences (ASMB) over the last 4 years, with Dec 2024 value amounting to -$6.69.

  • Assembly Biosciences' EPS (Weighted Average and Diluted) rose 52.32% to -$0.72 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.79, marking a year-over-year increase of 30.78%. This contributed to the annual value of -$6.69 for FY2024, which is 50.00% up from last year.
  • Assembly Biosciences' EPS (Weighted Average and Diluted) amounted to -$6.69 in FY2024, which was up 50.00% from -$13.38 recorded in FY2023.
  • Assembly Biosciences' 5-year EPS (Weighted Average and Diluted) high stood at -$3 for FY2021, and its period low was -$23.08 during FY2022.
  • Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$13.38 (2023), whereas its average is -$14.38.
  • In the last 5 years, Assembly Biosciences' EPS (Weighted Average and Diluted) crashed by 669.33% in 2022 and then skyrocketed by 50.00% in 2024.
  • Over the past 4 years, Assembly Biosciences' EPS (Weighted Average and Diluted) (Yearly) stood at -$3 in 2021, then slumped by 669.33% to -$23.08 in 2022, then surged by 42.03% to -$13.38 in 2023, then soared by 50.00% to -$6.69 in 2024.